ZNF232 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.362000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.940600E-01
Normal-vs-Stage2
1.348980E-01
Normal-vs-Stage3
1.691590E-01
Normal-vs-Stage4
3.911900E-02
Stage1-vs-Stage2
3.141800E-01
Stage1-vs-Stage3
2.704000E-01
Stage1-vs-Stage4
2.860600E-01
Stage2-vs-Stage3
3.977400E-01
Stage2-vs-Stage4
8.539000E-01
Stage3-vs-Stage4
6.436200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.513200E-01
Normal-vs-AfricanAmerican
4.317800E-02
Normal-vs-Asian
3.175500E-02
Caucasian-vs-AfricanAmerican
9.309600E-01
Caucasian-vs-Asian
3.323000E-01
AfricanAmerican-vs-Asian
3.451200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.833010E-01
Normal-vs-Female
3.057800E-01
Male-vs-Female
3.868600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.394400E-01
Normal-vs-Age(41-60Yrs)
4.189400E-01
Normal-vs-Age(61-80Yrs)
1.266170E-01
Normal-vs-Age(81-100Yrs)
6.381800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.590600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.601200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.661200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.021700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.469400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.614000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.210400E-02
Normal-vs-Daily Drinker
1.658560E-01
Normal-vs-Weekly Drinker
1.469850E-01
Normal-vs-Occasional Drinker
5.309800E-01
Normal-vs-Social Drinker
6.775200E-01
Non Drinker-vs-Daily Drinker
8.749000E-01
Non Drinker-vs-Weekly Drinker
8.720600E-01
Non Drinker-vs-Occasional Drinker
6.575900E-02
Non Drinker-vs-Social Drinker
1.732840E-01
Daily Drinker-vs-Weekly Drinker
9.924800E-01
Daily Drinker-vs-Occasional Drinker
1.271040E-01
Daily Drinker-vs-Social Drinker
1.622980E-01
Weekly Drinker-vs-Occasional Drinker
1.558030E-01
Weekly Drinker-vs-Social Drinker
2.068000E-01
Occasional Drinker-vs-Social Drinker
9.074600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.615600E-01
Normal-vs-Grade 2
9.247800E-01
Normal-vs-Grade 3
8.998200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.838200E-02
Grade 1-vs-Grade 3
2.773900E-02
Grade 1-vs-Grade 4
7.615600E-01
Grade 2-vs-Grade 3
6.416200E-01
Grade 2-vs-Grade 4
9.247800E-01
Grade 3-vs-Grade 4
8.998200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.739700E-02
Normal-vs-NonDiabetic
3.438000E-01
Diabetic-vs-NonDiabetic
4.754400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.656800E-01
Normal-vs-NoPancreatitis
2.169200E-01
Pancreatitis-vs-NoPancreatitis
9.539400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.457200E-01
Normal-vs-N1
1.187550E-01
N0-vs-N1
4.532000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.180300E-02
Normal-vs-TP53-NonMutant
8.498600E-01
TP53-Mutant-vs-TP53-NonMutant
1.957420E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
